10.8 C
Munich
Friday, March 24, 2023
type here...

CATEGORY

BioPharma

BioPharma

Bioadaptives Inc (OTCMKTS: BDPT) in Focus as Co Signs LOI to Create Fit Your Outfit (FYO) App Utilizing AI to Scientifically Measures Body Composition

Boe Rimes -
Bioadaptives Inc (OTCMKTS: BDPT) is breaking out northbound off its triple zero lows of $0.005. The stock is now well into the double zeroes...
BioPharma

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) Breaking Out as MIA License Issued to Sawston GMP Facility, Biotech Unveils 2023 Initiatives Following DCVax®-L Positive TLR for...

Boe Rimes -
Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) is running northbound after the biotech reported that the Company, along with its partner Advent BioServices, a leading contract...
BioPharma

Revive Therapeutics Ltd (CSE: RVV) (OTCMKTS: RVVTF) Reverses off 52 Week Lows as FDA Adjusts Endpoints in Bucillamine Trials (More on RVV Psilocybin Clinical...

Boe Rimes -
Revive Therapeutics Ltd (OTCMKTS: RVVTF) is a biotech sleeper that hit new 52 week lows on Monday after the FDA adjusted the endpoints of...
BioPharma

Viaderma Inc (OTCMKTS: VDRM) Red Hot as Biotech Relaunches Vitastem and Vitastem Ultra & Awaits FDA Registration Status Approval for Nupelo

Boe Rimes -
Viaderma Inc (OTCMKTS: VDRM) is an exciting biotech currently making a big move up the charts in recent weeks from a start point off...
BioPharma

Tenax Therapeutics, Inc. (NASDAQ:TENX) Reverses Northbound off New 52 Week Lows as Biotech Advances Lmatinib (TNX-201) & Levosimendan (TNX-102)

Boe Rimes -
Tenax Therapeutics, Inc. (NASDAQ:TENX) recently made a strong reversal off new 52-week lows of $0.45 per share and is currently trading just a little...
BioPharma

Humbl Inc (OTCMKTS: HMBL) Right Under a Penny HMBL Cancels RS and Launches HUMBL Digital Wallet offering Digital Assets, a Search Engine and Social...

Van Leopold -
Humbl Inc (OTCMKTS: HMBL) is a sleeper trading just over 52-week lows of $0.0067 and the stock still trades well over $100,000 in dollar...
BioPharma

Akebia Therapeutics Inc (NASDAQ: AKBA) Heating Up as Auryxia Sales Accelerate & FDA Office of New Drugs (OND) Conducts Final Review on Vadadustat for...

Van Leopold -
Akebia Therapeutics Inc (NASDAQ: AKBA) is an exciting low priced Nasdaq biotech advancing Vadadustat; an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor currently in...
BioPharma

Vivos Inc (OTCMKTS: RDGL) Heating Up as Biotech Files More Patents & Prepares for Upcoming IDE Submittal

Van Leopold -
Vivos Inc (OTCMKTS: RDGL) continues to move steadily northbound taking out the highs of early February and moving back over $0.07 with steady buying...
BioPharma

Exela Technologies Inc (NASDAQ: XELA) Reverses off 52 Week Lows as Earnings Reports Looms & Investors wait on European Merger News, NASDAQ Update and...

Van Leopold -
Exela Technologies Inc (NASDAQ: XELA) has been on the move in recent days moving up over its $0.05 base and 52-week lows of $0.04...
BioPharma

Can B Corp (OTCMKTS: CANB) Getting Noticed After Posting Significant Revenues Growth of 51% & Reversing of $0.45 Lows

Boe Rimes -
Can B Corp (OTCMKTS: CANB) has made a significant reversal off $0.45 after many months of declines and volume has picked up substantially as...
1234Page 1 of 4

Latest news

© All rights reserved.

About Us

Popular Category

Editor Picks